Allergan, Inc. (NYSE:AGN) announced the U.S. Food and Drug Administration’s (FDA) approval of JUVEDERM(R) XC, a new formulation of the currently FDA-approved JUVEDERM(R) dermal filler and the latest advancement1 in hyaluronic acid (HA) dermal fillers.
SAN MATEO, Calif. and PARIS, Jan. 8, 2009 (GLOBE NEWSWIRE) — BioForm Medical, Inc.
SAN MATEO, Calif., December 12, 2007 /PRNewswire-FirstCall/ — BioForm Medical, Inc. today announced the publication of a multi-center, randomized, blinded comparative study of nasolabial fold treatments reporting higher patient satisfaction with… (Source: Drugs.com – Clinical Trials)
The FDA has approved a series of hyaluronic acid gel implants (Juvederm 24HV, 30, and 30HV) and a gastrointestinal monitoring device (SmartPill pH.p).Medscape Medical NewsYael Waknine (Source: Medscape Medical News Headlines)
Copryright 2012 - Epione Medical Corporation | About us | Treatments | Contact us | Online Store